Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
Cancer Immunology, Immunotherapy · 2024
DOI: 10.1007/s00262-024-03853-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Xinjun Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pancreatic-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. Hauptthemen laut MEDLINE: Liver Transplantation, Carcinoma, Hepatocellular, Liver Neoplasms, Graft Rejection. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Basic and Applied Basic Research Foundation, Science and Technology Program of Guangzhou, Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pancreatic-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China.
- Department of Pancreatobiliary Surgery, Sun Yat-Sen University Cancer Center, Guangzhou, China.
- Department of Pancreatic-Biliary Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China. liuchao3@mail.sysu.edu.cn.
Förderung
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Program of Guangzhou
- Natural Science Foundation of China
- Sun Yat-sen Pilot Scientific Research Fund
- Sun Yat-Sen University Clinical Research 5010 Program
- Sun Yat-Sen Memorial Hospital Clinical Research 5010 Program
- Guangzhou Key Laboratory of Precise Diagnosis and Treatment of Biliary Tract Cancer
Zitieren
APA
Lu, X., Zhu, Q., Cai, J., Yang, Z., Gu, G., Pang, L., Su, M., Zhang, F., Lin, H., Wu, W., Xu, L., & Liu, C. (2024). Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03853-9
Vancouver
Lu X, Zhu Q, Cai J, Yang Z, Gu G, Pang L, et al. Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03853-9
BibTeX
@article{Lu2024,
author = {Lu, Xinjun and Zhu, Qi and Cai, Junfeng and Yang, Zuozhong and Gu, Guangxiang and Pang, Li and Su, Mingye and Zhang, Fapeng and Lin, Haoming and Wu, Wenrui and Xu, Leibo and Liu, Chao},
title = {Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation},
journal = {Cancer Immunology, Immunotherapy},
year = {2024},
doi = {10.1007/s00262-024-03853-9}
}
EUVIMED